# INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

> **NCT03547297** · — · TERMINATED · sponsor: **Alnylam Pharmaceuticals** · enrollment: 212 (actual)

## Conditions studied

- Acute Hepatic Porphyria
- Hepatic Porphyrias
- Acute Intermittent Porphyria (AIP)
- Hereditary Coproporphyria (HCP)
- Variegate Porphyria (VP)
- ALA Dehydratase Deficient Porphyria (ADP)
- Porphyria Acute

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03547297
- **Lead sponsor:** Alnylam Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-29
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-15
- **Target enrollment:** 212 (ACTUAL)
- **Why stopped:** Sponsor elected not to continue with study
- **Last updated:** 2019-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547297, "INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03547297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*